DCP Results Neutral

DIS-CHEM PHARMACIES LIMITED - Audited Annual Consolidated Results for the twelve months ended 28 February 2026 and dividend declaration

Dis-Chem Pharmacies Limited
Free preview

What this filing means

Dis-Chem reported a 17.3% HEPS decline as heavy ecosystem investments masked strong 9.3% revenue growth and improving operational margins.

Bull case

  • Group revenue grew by 9.3% to R42.8 billion, underpinned by a 13.1% increase in wholesale revenue.
  • Profit before tax, excluding ecosystem investments and non-recurring expenses, increased by 20.1% to R1.8 billion.

Bear case

  • Headline earnings per share (HEPS) declined by 17.3% to 113.7 cents as heavy ecosystem investments weighed heavily on near-term profitability.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

Unlock the full analysis

Free during launch. Sign in to read the complete breakdown.

  • Full bull / bear breakdown
  • Decision framework
  • Citations & sources
  • Price autopsy
Sign in for full analysis
Category
Results
Event posture
No Edge
Published
May 29, 2026

More on Dis-Chem Pharmacies Limited

Related filings